Neovascularization of engineered tissues for clinical translation: where we are, where we should be?

MLA

Neovascularization of Engineered Tissues for Clinical Translation: Where We Are, Where We Should Be? Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3076..5b801af3edff424bcbe303e7f3afcc7b&authtype=sso&custid=ns315887.

APA

Neovascularization of engineered tissues for clinical translation: where we are, where we should be? (2021).

Chicago

“Neovascularization of Engineered Tissues for Clinical Translation: Where We Are, Where We Should Be?” 2021, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3076..5b801af3edff424bcbe303e7f3afcc7b&authtype=sso&custid=ns315887.